Observational Study
Copyright ©The Author(s) 2017.
World J Diabetes. Apr 15, 2017; 8(4): 154-164
Published online Apr 15, 2017. doi: 10.4239/wjd.v8.i4.154
Table 3 Differences between Study Phases for Biochemical and Anthropometric Parameters
MeasurementMean ± SD Phase 1Mean ± SD Phase 2Mean ± SD Phase 3Mean difference Phase 1 to 2Mean difference Phase 2 to 3Mean difference Phase 1 to 3
Clinical outcome
Weight (kg)100.6 ± 21.799.2 ± 21.399.5 ± 21.5-1.4 (P = 0.009)+0.28 (P = 1.0)-1.12 (P = 0.08)
BMI (kg/m2)36.9 ± 8.336.4 ± 8.136.5 ± 8.1-0.52 (P = 0.01)+0.1 (P = 1.0)-0.42 (P = 0.09)
Waist circumference (cm)109.6 ± 11.1107.8 ± 11.1107.5 ± 10.9-1.75 (P = 0.086)-0.30 (P = 1.0)-2.05 (P = 0.24)
Systolic BP (mmHg)130.0 ± 17.8127.0 ± 21.4128.5 ± 14.3-3 (P = 0.83)+1.5 (P = 1.0)-1.5 (P = 1.0)
Diastolic BP (mmHg)80.5 ± 13.279.8 ± 15.781.7 ± 12.2-0.72 (P = 1.0)+1.9 (P = 0.76)+1.2 (P = 1.0)
Daily hours fasted11.6 ± 1.916.8 ± 1.211.5 ± 2.0+5.2 (P < 0.005)-5.3 (P < 0.005)-0.09 (P = 1.0)
Biochemical outcome
C-reactive protein (mg/L)4.3 ± 3.84.0 ± 3.74.1 ± 3.5-0.3 (P = 0.9)+0.09 (P = 1.0)-0.25 (P = 1.0)
HOMA-IR6.9 ± 3.06.5 ± 2.46.6 ± 3.0-0.46 (P = 1.0)+0.11 (P = 1.0)-0.35 (P = 1.0)